Enanta Pharmaceuticals (ENTA) Other Non-Current Assets (2012 - 2026)

Enanta Pharmaceuticals (ENTA) has 15 years of Other Non-Current Assets data on file, last reported at $3.4 million in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.0% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.4 million, up 3474.47% from the prior year.
• Other Non-Current Assets rose to $3.4 million in Q1 2026, from $93000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.0 million in Q3 2022 to a low of $92000.0 in Q1 2022.
• A 5-year average of $2.1 million and a median of $3.4 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 97.63% — and 2025, when it surged 3474.47%.
• Tracing ENTA's Other Non-Current Assets over 5 years: stood at $701000.0 in 2022, then jumped by 466.05% to $4.0 million in 2023, then sank by 97.63% to $94000.0 in 2024, then dropped by 1.06% to $93000.0 in 2025, then surged by 3512.9% to $3.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.4 million (Q1 2026), $93000.0 (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.